1. Home
  2. CCTG vs LIXT Comparison

CCTG vs LIXT Comparison

Compare CCTG & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCTG
  • LIXT
  • Stock Information
  • Founded
  • CCTG 1993
  • LIXT 2005
  • Country
  • CCTG Hong Kong
  • LIXT United States
  • Employees
  • CCTG N/A
  • LIXT N/A
  • Industry
  • CCTG
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCTG
  • LIXT Health Care
  • Exchange
  • CCTG Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • CCTG 12.5M
  • LIXT 12.4M
  • IPO Year
  • CCTG 2024
  • LIXT N/A
  • Fundamental
  • Price
  • CCTG $1.13
  • LIXT $4.62
  • Analyst Decision
  • CCTG
  • LIXT
  • Analyst Count
  • CCTG 0
  • LIXT 0
  • Target Price
  • CCTG N/A
  • LIXT N/A
  • AVG Volume (30 Days)
  • CCTG 8.1K
  • LIXT 118.9K
  • Earning Date
  • CCTG 09-26-2025
  • LIXT 08-07-2025
  • Dividend Yield
  • CCTG N/A
  • LIXT N/A
  • EPS Growth
  • CCTG N/A
  • LIXT N/A
  • EPS
  • CCTG N/A
  • LIXT N/A
  • Revenue
  • CCTG $17,631,489.00
  • LIXT N/A
  • Revenue This Year
  • CCTG N/A
  • LIXT N/A
  • Revenue Next Year
  • CCTG N/A
  • LIXT N/A
  • P/E Ratio
  • CCTG N/A
  • LIXT N/A
  • Revenue Growth
  • CCTG 19.55
  • LIXT N/A
  • 52 Week Low
  • CCTG $0.99
  • LIXT $0.64
  • 52 Week High
  • CCTG $3.17
  • LIXT $5.14
  • Technical
  • Relative Strength Index (RSI)
  • CCTG 57.30
  • LIXT 60.73
  • Support Level
  • CCTG $1.07
  • LIXT $3.20
  • Resistance Level
  • CCTG $1.12
  • LIXT $4.60
  • Average True Range (ATR)
  • CCTG 0.05
  • LIXT 0.49
  • MACD
  • CCTG 0.01
  • LIXT 0.04
  • Stochastic Oscillator
  • CCTG 45.45
  • LIXT 99.75

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: